Harvard Bioscience, Inc. (HBIO) Reports Q1 EPS of $0.09; Guides Q2
Tweet Send to a FriendGet Alerts HBIO Hot Sheet
Price: $5.20 -0.57%
Revenue Growth %: -7.8%
Financial Fact:
Restructuring charges: -21K
Today's EPS Names:
LBIX, ESEA, ISS, More
Revenue Growth %: -7.8%
Financial Fact:
Restructuring charges: -21K
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade HBIO Now!
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q1 EPS of $0.09, versus $0.08 reported last year. Revenue for the quarter came in at $28.3 million, versus $26.3 million reported last year.
Harvard Bioscience, Inc. sees Q2 2012 EPS of $0.06-$0.06. Harvard Bioscience, Inc. sees Q2 2012 revenue of $28-$29 million.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Harvard Bioscience, Inc. sees Q2 2012 EPS of $0.06-$0.06. Harvard Bioscience, Inc. sees Q2 2012 revenue of $28-$29 million.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Agilent (A) Tops Q2 EPS by 9c, Trims FY13 Outlook; Adds to Buyback, Will Cut Jobs
- Orient Paper, Inc. (ONP) Reports Q1 EPS of $0.02; Guides FY13
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
